Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AMES + Brain Stimulation: Treatment for Profound Plegia in Stroke

NCT01169181 is registered in ClinicalTrials.gov with AMES Technology as lead sponsor.

NCT NCT01169181
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01169181 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AMES + Brain Stimulation: Treatment for Profound Plegia in Stroke
Lead sponsor
AMES Technology
Phase
Phase 1
Overall status
Unknown status
Start date
July 31, 2010
Completion date
December 31, 2019
Enrollment
6 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebrovascular accident, plegia, stroke